Vascular endothelial growth factor (VEGF) isoform VEGF165b inhibits VEGF-R2 mediated phosphorylation of p44/p42 MAP kinase in vitro

University of Cambridge (2004) J Physiol 555P, C80

Communications: Vascular endothelial growth factor (VEGF) isoform VEGF165b inhibits VEGF-R2 mediated phosphorylation of p44/p42 MAP kinase in vitro

H.S. Bevan, J. Woolard, S.J. Harper and D.O. Bates

Microvascular Research Laboratories, Department of Physiology, University of Bristol, Southwell Street, Bristol BS2 8EJ, UK

View other abstracts by:


VEGF is essential for vasculogenesis, development of the embryonic vasculture and is a potent angiogenic factor in pathological angiogenesis. Here we determined the effect a novel splice variant of VEGF, VEGF165b on VEGF-R2 receptor tyrosine kinase mediated phosphorylation of mitogen activated protein kinase (p42/p44 MAPK).

Chinese Hamster Ovary cells (CHOs) were transfected with either an empty vector (pcDNA3) or VEGF-R2 containing expression vector. Cells were incubated with media or with media containing 1 nM VEGF165, 1 nM VEGF165b, or 1 nM VEGF165 and 1 nM VEGF165b for 20 min at 37°C. Western blot analysis was used to determine whether VEGF165b inhibits VEGF-R2 induced phosphorylation of MAPK by using specific antibodies against phospho-p44/p42 MAP kinases.

A basal level p44/p42 MAP kinase phosphorylation was detected in pcDNA3 transfected cells, regardless of treatment. A similar p44/p42 MAP kinase phosphorylation level was observed in VEGF-R2 transfected cells that were incubated in the absence of a VEGF isoform (control). As expected, VEGF165 increased the intensity of the phosphorylated polypeptide band by mean ± S.E.M. 222 ± 60 % of the untreated cells. In contrast, when VEGF-R2 transfected cells were treated with VEGF165b, only a small increase (122 ± 42 %) in the level of p44/p42 MAPK kinase phosphorylation was detected compared to control. This was significantly lower than that of VEGF165-induced stimulation (paired t test, P < 0.05). Treatment of VEGF-R2 transfected cells with a combination of both VEGF165 and VEGF165b, resulted in an 190 ± 56 % increase in the level of p44/p42 MAP Kinase phosphorylation compared to the control.

These results show that the intensity of VEGF165b-induced phosphorylation of the signalling proteins p44/p42 MAP kinases is significantly less than that detected for VEGF165-induced stimulation. Furthermore, combination of VEGF165 and VEGF165b-induced phosphorylation of p44/p42 MAP kinases was 32 % less than that detected for VEGF165-induced stimulation. VEGF165b therefore appears to be able to inhibit VEGF mediated signalling through VEGF-R2.

This work was supported by Wellcome Trust Grant 69029



Where applicable, experiments conform with Society ethical requirements.

Site search

Filter

Content Type